中国研究型医院2024,Vol.11Issue(5) :69-72.DOI:10.19450/j.cnki.jcrh.2024.05.010

miRNA在心力衰竭及并发症中的研究进展

Research progress on miRNA in heart failure and its complications

刘晓彬 秦宇 冯镜洁 文江平
中国研究型医院2024,Vol.11Issue(5) :69-72.DOI:10.19450/j.cnki.jcrh.2024.05.010

miRNA在心力衰竭及并发症中的研究进展

Research progress on miRNA in heart failure and its complications

刘晓彬 1秦宇 1冯镜洁 1文江平1
扫码查看

作者信息

  • 1. 清华大学第一附属医院检验科,北京 100016
  • 折叠

摘要

心力衰竭(HF)是各种心脏疾病终末期导致的心功能失代偿的临床综合征.大量研究表明,部分微RNA(miRNA)在心律失常、心肌纤维化、心肌梗死等心血管疾病的发生发展中具有关键作用,而相关miRNA表达与HF患者的进展和不良结局紧密相关,已成为包括HF在内多种疾病极具前景的治疗靶点.因此,笔者通过阐述miRNA的生物特性,就HF及合并慢性阻塞性肺疾病、慢性肾脏病诊断中的相关miRNA标志物展开综述,以期为临床实践提供帮助.

Abstract

Heart failure (HF) is a clinical syndrome characterized by the decompensation of cardiac function,resulting from the end stage of various heart diseases. Numerous studies have demonstrated that certain microRNAs (miRNAs) play crucial roles in the occurrence and development of cardiovascular diseases such as arrhythmias,myocardial fibrosis,and myocardial infarction. The expression of these miRNAs is closely related to the progression and adverse outcomes in HF patients,making them promising therapeutic targets for various diseases,including HF.The authors of this review discusse the biological characteristics of miRNAs and focuses on related miRNA biomarkers in the diagnosis of HF and its complications,such as chronic obstructive pulmonary disease and chronic kidney disease,with the aim of providing guidance for clinical practice.

关键词

心力衰竭/微RNAs/肺疾病,慢性阻塞性/心肾综合征

Key words

Heart failure/MicroRNAs/Pulmonary disease/Chronic obstructive/Cardiorenal syndrome

引用本文复制引用

出版年

2024
中国研究型医院

中国研究型医院

ISSN:
段落导航相关论文